Literature DB >> 29095416

Rolling-out Screening Volume Affecting Compliance Rate and Waiting Time of FIT-based Colonoscopy.

Hsiao-Hsuan Jen1, Chen-Yang Hsu1, Sam Li-Sheng Chen2, Amy Ming-Fang Yen2, Sherry Yueh-Hsia Chiu3, Jean Ching-Yuan Fann4, Yi-Chia Lee5, Ming-Shiang Wu5, Wen-Feng Hsu1,6, Szu-Min Peng1, Hsiu-Hsi Chen1, Han-Mo Chiu5.   

Abstract

BACKGROUND AND STUDY AIMS: The population-based colorectal cancer screening program with fecal immunochemical test (FIT) from the inaugural period to the rolling-out period may create a higher demand for colonoscopies, but such a change has not been quantified. We intended to assess the change in the compliance rate and the waiting time (WT) for a colonoscopy and the associated geographic and institutional variations across the 2 periods.
MATERIALS AND METHODS: Data from the Taiwanese nationwide colorectal cancer screening program were analyzed. The data included a total of 46,235 FIT-positive cases of 1,258,560 tests in the inaugural period (2004 to 2009) and 270,700 FIT-positive cases of 3,723,789 tests in the rolling-out period (2010 to 2013). The compliance rate and WT for colonoscopy after positive FIT was ascertained and compared between the 2 periods.
RESULTS: The rolling-out period resulted in a decline of 16.0% for compliance rate and yielded an additional 1,778,499 waiting days with variation across geography and institution. After adjusting for relevant factors, a decrease in compliance rate by 8.5% and an increase of 714,648 waiting days were still noted. In the rolling-out period, a remarkable decline in compliance rate by 9.8% was found in middle Taiwan, and the longest WT (1,260,109 d) was observed in southern Taiwan. Screening at public health centers led to a 19% decrease in compliance rate and an increase of 2,546,746 waiting days.
CONCLUSIONS: The decrease in compliance rate and an increase in the WT with variation across geography and institution resulting from the increased volume of rolling-out FIT screening provide an insight into optimal resource allocation of clinical capacity for colonoscopy.

Entities:  

Mesh:

Year:  2018        PMID: 29095416     DOI: 10.1097/MCG.0000000000000955

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  4 in total

Review 1.  Causes of Socioeconomic Disparities in Colorectal Cancer and Intervention Framework and Strategies.

Authors:  John M Carethers; Chyke A Doubeni
Journal:  Gastroenterology       Date:  2019-11-01       Impact factor: 22.682

2.  The Addition of Other Fecal Biomarkers Does Not Improve the Diagnostic Accuracy of Immunochemical Fecal Occult Blood Test Alone in a Colorrectal Cancer Screening Cohort.

Authors:  Gonzalo Hijos-Mallada; Alberto Lué; Raul Velamazan; Nuria Saura; Carlos Abril; Marta Lorenzo; Mercedes Navarro; Eduardo Chueca; Samantha Arechavaleta; Fernando Gomollón; Ángel Lanas; Carlos Sostres
Journal:  Front Med (Lausanne)       Date:  2021-06-04

3.  Long-term effectiveness of faecal immunochemical test screening for proximal and distal colorectal cancers.

Authors:  Han-Mo Chiu; Grace Hsiao-Hsuan Jen; Ying-Wei Wang; Jean Ching-Yuan Fann; Chen-Yang Hsu; Ya-Chung Jeng; Amy Ming-Fang Yen; Sherry Yueh-Hsia Chiu; Sam Li-Sheng Chen; Wen-Feng Hsu; Yi-Chia Lee; Ming-Shiang Wu; Chien-Yuan Wu; Yann-Yuh Jou; Tony Hsiu-Hsi Chen
Journal:  Gut       Date:  2021-01-25       Impact factor: 23.059

4.  Impact of COVID-19 pandemic on fecal immunochemical test screening uptake and compliance to diagnostic colonoscopy.

Authors:  Shao-Yi Cheng; Chu-Fen Chen; Hsien-Chin He; Li-Chun Chang; Wen-Feng Hsu; Ming-Shiang Wu; Han-Mo Chiu
Journal:  J Gastroenterol Hepatol       Date:  2020-12-02       Impact factor: 4.369

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.